Printer Friendly

Johnson and Johnson Closes USD 3.4bn Acquisition of Auris Health, Expanding Digital Surgery Portfolio.


4 April 2019 - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) Ethicon, Inc. business has closed the acquisition of robotic technologies developer Auris Health, Inc. for approximately USD 3.4bn in cash, the company said.

Additional contingent payments of up to USD 2.35bn, in the aggregate, may be payable upon reaching certain predetermined milestones.

Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures.

This acquisition will accelerate Johnson and Johnson's entry into robotics with potential for growth and expansion into other interventional applications.

With this acquisition, Frederic Moll, M.D., CEO and founder of Auris Health and a visionary in the field of surgical robotics, will be joining Johnson and Johnson upon completion of this transaction.

Ethicon, Inc. is a subsidiary of Johnson and Johnson. It was incorporated as a separate company under the Johnson and Johnson umbrella in 1949 to expand and diversify the Johnson and Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887.

Country: USA

Sector: Healthcare

Target: Auris Health, Inc

Buyer: Johnson and Johnson/ Ethicon


Deal size in USD: 3.4bn

Type: Corporate Acquisition

Financing: Cash

Status: Closed

Buyer advisor: , ,


COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Apr 4, 2019
Previous Article:The Jordan Company Acquires US Manufacturer Arch Global Precision.
Next Article:Horizon North Logistics Closes Acquisition of Modular Construction Provider NRB Canada.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |